- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Circulating Biomarker market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Circulating Biomarker market. Detailed analysis of key players, along with key growth strategies adopted by Circulating Biomarker industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bio-Rad Laboratories (US)
Myriad Genetics (US)
QIAGEN (Netherlands)
Roche (Switzerland)
Janssen Diagnostics (US)
MDxHealth SA (US)
Biocept Inc (US)
Trovagene (US)
Fraunhofer-Gesellschaft (Germany)
Guardant Health (US)
By Type:
Lung
Breast
Colorectal
Prostate
By End-User:
Reference Laboratory
Research Centers
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Circulating Biomarker Market
-
1.3 Market Segment by Type
-
1.3.1 China Circulating Biomarker Market Size and Growth Rate of Lung from 2016 to 2027
-
1.3.2 China Circulating Biomarker Market Size and Growth Rate of Breast from 2016 to 2027
-
1.3.3 China Circulating Biomarker Market Size and Growth Rate of Colorectal from 2016 to 2027
-
1.3.4 China Circulating Biomarker Market Size and Growth Rate of Prostate from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Circulating Biomarker Market Size and Growth Rate of Reference Laboratory from 2016 to 2027
-
1.4.2 China Circulating Biomarker Market Size and Growth Rate of Research Centers from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Circulating Biomarker Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Circulating Biomarker by Major Types
-
3.4.1 Market Size and Growth Rate of Lung
-
3.4.2 Market Size and Growth Rate of Breast
-
3.4.3 Market Size and Growth Rate of Colorectal
-
3.4.4 Market Size and Growth Rate of Prostate
4 Segmentation of Circulating Biomarker Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Circulating Biomarker by Major End-Users
-
4.4.1 Market Size and Growth Rate of Circulating Biomarker in Reference Laboratory
-
4.4.2 Market Size and Growth Rate of Circulating Biomarker in Research Centers
5 Market Analysis by Regions
-
5.1 China Circulating Biomarker Production Analysis by Regions
-
5.2 China Circulating Biomarker Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Circulating Biomarker Landscape Analysis
-
6.1 North China Circulating Biomarker Landscape Analysis by Major Types
-
6.2 North China Circulating Biomarker Landscape Analysis by Major End-Users
7 Central China Circulating Biomarker Landscape Analysis
-
7.1 Central China Circulating Biomarker Landscape Analysis by Major Types
-
7.2 Central China Circulating Biomarker Landscape Analysis by Major End-Users
8 South China Circulating Biomarker Landscape Analysis
-
8.1 South China Circulating Biomarker Landscape Analysis by Major Types
-
8.2 South China Circulating Biomarker Landscape Analysis by Major End-Users
9 East China Circulating Biomarker Landscape Analysis
-
9.1 East China Circulating Biomarker Landscape Analysis by Major Types
-
9.2 East China Circulating Biomarker Landscape Analysis by Major End-Users
10 Northeast China Circulating Biomarker Landscape Analysis
-
10.1 Northeast China Circulating Biomarker Landscape Analysis by Major Types
-
10.2 Northeast China Circulating Biomarker Landscape Analysis by Major End-Users
11 Southwest China Circulating Biomarker Landscape Analysis
-
11.1 Southwest China Circulating Biomarker Landscape Analysis by Major Types
-
11.2 Southwest China Circulating Biomarker Landscape Analysis by Major End-Users
12 Northwest China Circulating Biomarker Landscape Analysis
-
12.1 Northwest China Circulating Biomarker Landscape Analysis by Major Types
-
12.2 Northwest China Circulating Biomarker Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bio-Rad Laboratories (US)
-
13.1.1 Bio-Rad Laboratories (US) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Myriad Genetics (US)
-
13.2.1 Myriad Genetics (US) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 QIAGEN (Netherlands)
-
13.3.1 QIAGEN (Netherlands) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Roche (Switzerland)
-
13.4.1 Roche (Switzerland) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Janssen Diagnostics (US)
-
13.5.1 Janssen Diagnostics (US) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 MDxHealth SA (US)
-
13.6.1 MDxHealth SA (US) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Biocept Inc (US)
-
13.7.1 Biocept Inc (US) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Trovagene (US)
-
13.8.1 Trovagene (US) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Fraunhofer-Gesellschaft (Germany)
-
13.9.1 Fraunhofer-Gesellschaft (Germany) Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Guardant Health (US)
-
13.10.1 Guardant Health (US) Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Circulating Biomarker Market Size and Growth Rate of Lung from 2016 to 2027
-
Figure China Circulating Biomarker Market Size and Growth Rate of Breast from 2016 to 2027
-
Figure China Circulating Biomarker Market Size and Growth Rate of Colorectal from 2016 to 2027
-
Figure China Circulating Biomarker Market Size and Growth Rate of Prostate from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Circulating Biomarker Market Size and Growth Rate of Reference Laboratory from 2016 to 2027
-
Figure China Circulating Biomarker Market Size and Growth Rate of Research Centers from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Circulating Biomarker Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Circulating Biomarker
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Circulating Biomarker by Different Types from 2016 to 2027
-
Table Consumption Share of Circulating Biomarker by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Lung
-
Figure Market Size and Growth Rate of Breast
-
Figure Market Size and Growth Rate of Colorectal
-
Figure Market Size and Growth Rate of Prostate
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Circulating Biomarker by Different End-Users from 2016 to 2027
-
Table Consumption Share of Circulating Biomarker by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Reference Laboratory
-
Figure Market Size and Growth Rate of Research Centers
-
Table China Circulating Biomarker Production by Regions
-
Table China Circulating Biomarker Production Share by Regions
-
Figure China Circulating Biomarker Production Share by Regions in 2016
-
Figure China Circulating Biomarker Production Share by Regions in 2021
-
Figure China Circulating Biomarker Production Share by Regions in 2027
-
Table China Circulating Biomarker Consumption by Regions
-
Table China Circulating Biomarker Consumption Share by Regions
-
Figure China Circulating Biomarker Consumption Share by Regions in 2016
-
Figure China Circulating Biomarker Consumption Share by Regions in 2021
-
Figure China Circulating Biomarker Consumption Share by Regions in 2027
-
Table North China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table North China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure North China Circulating Biomarker Consumption Share by Types in 2016
-
Figure North China Circulating Biomarker Consumption Share by Types in 2021
-
Figure North China Circulating Biomarker Consumption Share by Types in 2027
-
Table North China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table North China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure North China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure North China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure North China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table Central China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table Central China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Central China Circulating Biomarker Consumption Share by Types in 2016
-
Figure Central China Circulating Biomarker Consumption Share by Types in 2021
-
Figure Central China Circulating Biomarker Consumption Share by Types in 2027
-
Table Central China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table Central China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure Central China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure Central China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table South China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table South China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure South China Circulating Biomarker Consumption Share by Types in 2016
-
Figure South China Circulating Biomarker Consumption Share by Types in 2021
-
Figure South China Circulating Biomarker Consumption Share by Types in 2027
-
Table South China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table South China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure South China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure South China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure South China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table East China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table East China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure East China Circulating Biomarker Consumption Share by Types in 2016
-
Figure East China Circulating Biomarker Consumption Share by Types in 2021
-
Figure East China Circulating Biomarker Consumption Share by Types in 2027
-
Table East China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table East China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure East China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure East China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure East China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table Northeast China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table Northeast China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Circulating Biomarker Consumption Share by Types in 2016
-
Figure Northeast China Circulating Biomarker Consumption Share by Types in 2021
-
Figure Northeast China Circulating Biomarker Consumption Share by Types in 2027
-
Table Northeast China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table Northeast China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure Northeast China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure Northeast China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table Southwest China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table Southwest China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Circulating Biomarker Consumption Share by Types in 2016
-
Figure Southwest China Circulating Biomarker Consumption Share by Types in 2021
-
Figure Southwest China Circulating Biomarker Consumption Share by Types in 2027
-
Table Southwest China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table Southwest China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure Southwest China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure Southwest China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table Northwest China Circulating Biomarker Consumption by Types from 2016 to 2027
-
Table Northwest China Circulating Biomarker Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Circulating Biomarker Consumption Share by Types in 2016
-
Figure Northwest China Circulating Biomarker Consumption Share by Types in 2021
-
Figure Northwest China Circulating Biomarker Consumption Share by Types in 2027
-
Table Northwest China Circulating Biomarker Consumption by End-Users from 2016 to 2027
-
Table Northwest China Circulating Biomarker Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Circulating Biomarker Consumption Share by End-Users in 2016
-
Figure Northwest China Circulating Biomarker Consumption Share by End-Users in 2021
-
Figure Northwest China Circulating Biomarker Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bio-Rad Laboratories (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad Laboratories (US)
-
Figure Sales and Growth Rate Analysis of Bio-Rad Laboratories (US)
-
Figure Revenue and Market Share Analysis of Bio-Rad Laboratories (US)
-
Table Product and Service Introduction of Bio-Rad Laboratories (US)
-
Table Company Profile and Development Status of Myriad Genetics (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics (US)
-
Figure Sales and Growth Rate Analysis of Myriad Genetics (US)
-
Figure Revenue and Market Share Analysis of Myriad Genetics (US)
-
Table Product and Service Introduction of Myriad Genetics (US)
-
Table Company Profile and Development Status of QIAGEN (Netherlands)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN (Netherlands)
-
Figure Sales and Growth Rate Analysis of QIAGEN (Netherlands)
-
Figure Revenue and Market Share Analysis of QIAGEN (Netherlands)
-
Table Product and Service Introduction of QIAGEN (Netherlands)
-
Table Company Profile and Development Status of Roche (Switzerland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche (Switzerland)
-
Figure Sales and Growth Rate Analysis of Roche (Switzerland)
-
Figure Revenue and Market Share Analysis of Roche (Switzerland)
-
Table Product and Service Introduction of Roche (Switzerland)
-
Table Company Profile and Development Status of Janssen Diagnostics (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Diagnostics (US)
-
Figure Sales and Growth Rate Analysis of Janssen Diagnostics (US)
-
Figure Revenue and Market Share Analysis of Janssen Diagnostics (US)
-
Table Product and Service Introduction of Janssen Diagnostics (US)
-
Table Company Profile and Development Status of MDxHealth SA (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MDxHealth SA (US)
-
Figure Sales and Growth Rate Analysis of MDxHealth SA (US)
-
Figure Revenue and Market Share Analysis of MDxHealth SA (US)
-
Table Product and Service Introduction of MDxHealth SA (US)
-
Table Company Profile and Development Status of Biocept Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocept Inc (US)
-
Figure Sales and Growth Rate Analysis of Biocept Inc (US)
-
Figure Revenue and Market Share Analysis of Biocept Inc (US)
-
Table Product and Service Introduction of Biocept Inc (US)
-
Table Company Profile and Development Status of Trovagene (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trovagene (US)
-
Figure Sales and Growth Rate Analysis of Trovagene (US)
-
Figure Revenue and Market Share Analysis of Trovagene (US)
-
Table Product and Service Introduction of Trovagene (US)
-
Table Company Profile and Development Status of Fraunhofer-Gesellschaft (Germany)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fraunhofer-Gesellschaft (Germany)
-
Figure Sales and Growth Rate Analysis of Fraunhofer-Gesellschaft (Germany)
-
Figure Revenue and Market Share Analysis of Fraunhofer-Gesellschaft (Germany)
-
Table Product and Service Introduction of Fraunhofer-Gesellschaft (Germany)
-
Table Company Profile and Development Status of Guardant Health (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guardant Health (US)
-
Figure Sales and Growth Rate Analysis of Guardant Health (US)
-
Figure Revenue and Market Share Analysis of Guardant Health (US)
-
Table Product and Service Introduction of Guardant Health (US)
-